ghk-cu skin before and after vs. 3 months of peptide therapy 🪄 • smoother texture, more even tone, that looks healthier overall. Small peptide, big difference 💙 Ghk cu before and after

Across the cagrilintide clinical program, the dominant tolerability issues have been gastrointestinal: nausea, reduced appetite, constipation, and, less commonly, vomiting a profile shared with pramlintide and with GLP-1 agonists, and mechanistically expected from a compound that slows the stomach and engages the area postrema

[PMID: 3136107] PubMed record related to this compound for laboratory literature review

Tirzepatide currently holds an advantage due to its FDA approval and extensive clinical data supporting its use

Consequently, all Astra Labs GHK-Cu stock is supplied strictly for laboratory research purposes only not for human consumption, therapeutic use, or medical application

"I think that peptides should be avoided until we understand the safety of what we're injecting, and we understand the long-term outcomes of what we're getting